Aoxin Q & M Anticipates Rebound in H1 2024
Aoxin Q & M Anticipates Rebound in H1 2024
In the preceding half year, the company narrowed its net loss to $210,000 (CNY1.15m).The company reported a net loss of $210m in H1 2023.
公司在2023年上半年報告了21000萬元的淨虧損。
Aoxin Q & M Dental Group said it anticipates its January to June (H1 2024) net earnings to improve on a year-on-year basis, compared to the net loss recorded last year.
Aoxin Q&M牙科集團表示，預計其2024年1月至6月（2024年上半年）淨利潤將與去年同期相比有所改善，與去年記錄的淨虧損相比。
The rebound is heavily influenced by "the increase in revenue generated from primary healthcare and laboratory services as well as a general reduction in expenses."
復甦受到“初級醫療保健和實驗室服務收入增長以及一般支出減少”的影響。
In the preceding half year, the company narrowed its net loss to $210,000 (CNY1.15m).
在前一半年，公司將淨虧損縮小至210,000美元（人民幣1.15萬元）。
The profit guidance follows a preliminary review of the company's unaudited financial results for H1 2024. Full details will be disclosed on or before 14 August.
利潤指導基於公司2024年上半年未經審計的財務結果的初步審查。完整細節將在8月14日或之前披露。
($1.00 = CNY5.41)
（1.00美元=5.41人民幣）
譯文內容由第三人軟體翻譯。